Inventor · disambiguated record
Francine S. Grant
Also filed as: GRANT FRANCINE S
35 granted patents·3 pending applications·577 citations·filing 1994–2009
98Inventor score
Top patents by PatentIndex Score
38 records- 0198US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0294US6583139B1Compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2000·Granted Jun 24, 2003·56 cites·26 claims
- 0393US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 0492US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 0588US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 0687US6900179B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2001·Granted May 31, 2005·16 cites·13 claims
- 0786US7229970B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted Jun 12, 2007·2 cites·11 claims
- 0886US6586602B2Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2002·Granted Jul 1, 2003·10 cites·13 claims
- 0986US6545003B1Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Apr 8, 2003·23 cites·7 claims
- 1085US7973044B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 5, 2011·4 cites·19 claims
- 1185US7452912B2Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Nov 18, 2008·19 cites·11 claims
- 1284US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 1384US5484940ASubstituted 3-indolyl-5-pyrazolone compoundsFiled 1994·Granted Jan 16, 1996·27 cites·11 claims
- 1483US7320960B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Jan 22, 2008·5 cites·20 claims
- 1583US6525026B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Feb 25, 2003·9 cites·18 claims
- 1681US7968547B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jun 28, 2011·2 cites·10 claims
- 1781US6489300B1Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 1998·Granted Dec 3, 2002·40 cites·22 claims
- 1880US7288526B2Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Oct 30, 2007·5 cites·16 claims
- 1980US6953802B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2001·Granted Oct 11, 2005·13 cites·28 claims
- 2079US6465513B1Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Oct 15, 2002·12 cites·14 claims
- 2178US7291645B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2003·Granted Nov 6, 2007·7 cites·6 claims
- 2277US7056937B2Sulfonylquinoxalone derivatives as bradykinin antagonistsELAN PHARM INC·Filed 2003·Granted Jun 6, 2006·11 cites·29 claims
- 2376US6291453B14-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Sep 18, 2001·20 cites·32 claims
- 2475US7223762B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 29, 2007·2 cites·17 claims
- 2575US7015216B2Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitorsWYETH CORP·Filed 2001·Granted Mar 21, 2006·8 cites·10 claims
- 2674US7166580B2Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jan 23, 2007·2 cites·11 claims
- 2772US7183281B2Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonistsELAN PHARM INC·Filed 2003·Granted Feb 27, 2007·6 cites·8 claims
- 2871US6803370B2Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Oct 12, 2004·4 cites·13 claims
- 2968US7115768B2Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Oct 3, 2006·3 cites·9 claims
- 3068US6423688B1Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Jul 23, 2002·16 cites·8 claims
- 3165US7074783B2Sulfonylbenzodiazepinone acetamides as bradykinin antagonistsELAN PHARM INC·Filed 2003·Granted Jul 11, 2006·2 cites·12 claims
- 3265US2008182850A13-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4ELAN PHARM INC·Filed 2007·Application pending·0 cites
- 3363US6559127B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted May 6, 2003·12 cites·15 claims
- 3456US6362341B1Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Mar 26, 2002·7 cites·18 claims
- 3555US7635775B2Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonistsELAN PHARM INC·Filed 2006·Granted Dec 22, 2009·0 cites·20 claims
- 3654US7030114B1Compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 1998·Granted Apr 18, 2006·8 cites·16 claims
- 3754US2006074110A1Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Application pending·0 cites
- 3852US2004006093A1Compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francine S. Grant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →